1-1 of 1
Max E Scheulen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MGN1703, a Novel TLR9-Agonist - Results of a Phase 1 Clinical Trial in Patients with Metastatic Malignancies.

Martin R Weihrauch, Manuel Schmidt, Marina Tschaika, Heike Richly, Michael S von Bergwelt-Baildon, Ulrich Hacker, Alexander Shimabokuro-Vornhagen, Burghardt Wittig, Max E Scheulen
Journal: Blood
Blood (2009) 114 (22): 4730.
https://doi.org/10.1182/blood.V114.22.4730.4730
Published: 2009